Joshua J. Lingo

Also affiliated with University of Colorado Anschutz Medical Campus

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond”.

Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond

Frontiers in Immunology(2020)10.3389/fimmu.2020.01681

N/A

0DataRank · unranked

114 citations

Joshua J. Lingo, Sherry D. Fleming, Jean F. Regal, Guillermina Girardi

CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0749

N/A

0DataRank · unranked

27 citations

Joshua J. Lingo, Courtney A. Kaemmer, Amanda Scherer, Akshaya Warrier, Ellen Voigt +20 more

Biodistribution Analysis of Peptide-Coated Magnetic Iron Nanoparticles: A Simple and Quantitative Method

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.11.561862

N/A

0DataRank · unranked

0 citations

Katherine Horak, Jennifer M. Rowe, Joshua J. Lingo, John M. Tomich, Sherry D. Fleming +1 more

Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors

Oncotarget(2024)10.18632/oncotarget.28650

N/A

0DataRank · unranked

3 citations

Ellen Voigt, Dawn E. Quelle, Joshua J. Lingo

Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath Tumors

Cancers(2025)10.3390/cancers17142410

N/A

0DataRank · unranked

7 citations

E. Elias, Dawn E. Quelle, Joshua J. Lingo